Kerri Fitzgerald

DocwireNews

Here are the top stories covered by DocWire News this week in the Hematology &amp; Oncology section. This week, a survey found that cancer research has been impacted by COVID-19, the U.S. Food and Drug Administration (FDA) approved several therapies, and more.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/disney-movies-may-improve-quality-of-life-in-women-with-gynecologic-cancer-on-chemotherapy/">Women&nbsp;with gynecologic cancers</a> may find themselves in a whole new world of improved quality of life by tuning into Disney movies, according to a study.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/survey-half-of-cancer-research-halted-due-to-covid-19/">According to a survey from the American Cancer Society</a>, just more than half of grantees reported that their cancer research or training activities had been put on hold due to the&nbsp;COVID-19 pandemic.<a href="https://www.docwirenews.com/hematology-oncology/fda-approves-lynparza-plus-avastin-combo-for-gynecologic-cancers/">The FDA approved Lynparza&reg;</a> (olaparib) in combination with Avastin&reg; (bevacizumab) for first-line maintenance treatment of adults with advanced epithelial&nbsp;ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency-positive status defined by either a deleterious or suspected deleterious&nbsp;BRCA&nbsp;mutation and/or genomic instability.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/fda-approves-targeted-treatment-for-lung-cancer-along-with-companion-diagnostic/">The FDA approved Tabrecta&trade;</a> (capmatinib) for adults with metastatic non-small cell lung cancer with the MET exon 14 skipping mutations, making it the first FDA approval to target these mutations.In case you missed it, more hem/onc headlines are featured below:<ul>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/fda-approves-retevmo-for-ret-mutated-lung-thyroid-cancers/">FDA Approves Retevmo&reg; for RET-Mutated Lung, Thyroid Cancers</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/obamacare-led-to-decrease-in-cancer-mortality-according-to-memorial-sloan-kettering-cancer-center-researchers/">Obamacare Led to Decrease in Cancer Mortality, According to Memorial Sloan Kettering Cancer Center Researchers</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/heres-how-primary-cancer-physicians-view-their-care-delivery-roles-for-survivors/">Here&rsquo;s How Primary Cancer Physicians View Their Care Delivery Roles for Survivors</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/scientists-develop-first-saliva-test-that-detects-throat-cancer-in-asymptomatic-patients/">Scientists Develop First Saliva Test That Detects Throat Cancer in Asymptomatic Patients</a></li>
</ul>

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Hem/Onc Roundup: Disney Movies Improve Cancer Quality of Life; FDA Approvals for Gynecologic, Lung Cancers; and more

Oncology

Here are the top stories covered by DocWire News this week in the Hematology &amp; Oncology section. This week, a survey found that cancer research has been impacted by ...

Hem/Onc Roundup: Disney Movies Improve Cancer Quality of Life; FDA Approvals for Gynecologic, Lung

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe